Versanis Bio Company Profile: Financials, Valuation, and Growth | PrivCo
Versanis Announces Initiation of the BELIEVE Global Phase 2b Study of Bimagrumab as a Novel Treatment for Obesity
Team – Versanis
News – Versanis
Versanis Bio begins enrolment in BELIEVE study for obesity
Versanis Bio on Twitter: "Welcome to the Versanis Board of Directors, John Maraganore @JMaraganore! John brings decades of proven strategic and operational leadership experience in biotechnology to help Versanis realize the full
About Us – Versanis
BioCentury - Versanis recruits Pruzanski as CEO, adds Maraganore, Duncan to board
Versanis Bio | LinkedIn
Versanis Bio - Crunchbase Company Profile & Funding